RPS20P20

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, RPS20P20 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPS20P20’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS20P20 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS20P20 is over-expressed in tumor.

KIRC and BRCA are the cancer types where RPS20P20 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS20P20 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
KIRCAllAll+0.031.0018view →
BRCAFemaleAll+0.092.0422view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPS20P20–KIRC

Tumor-vs-normal expression box plot for RPS20P20 RNA in KIRC.

Open the KIRC breakdown →

Exploration